We’ve talked a lot about HIPEC here – but we have not really talked about the risks of treatment. While we mentioned the arduous nature of the procedure itself, we’ve left more in-depth discussions to the oncologists.
Now researchers at the National Institute of Health have developed a tool to help clinicians and their patients determine the risks of HIPEC. In an article published over at Surviving Mesothelioma, the authors discuss their recent study and the results. Since the procedure itself carries significant mortality – the calculator offers an important tool for determining who the best candidates are for successful treatment with this procedure.
Schaub NP, Alimchandani M, Quezado M, Kalina P, Eberhardt JS, Hughes MS, Beresnev T, Hassan R, Bartlett DL, Libutti SK,Pingpank JF, Royal RE, Kammula US, Pandalai P, Phan GQ, Stojadinovic A, Rudloff U, Alexander HR, Avital I. (2012). A Novel Nomogram for Peritoneal Mesothelioma Predicts Survival. Ann Surg Oncol. 2012 Dec 12